Stiffening of the arteries, resulting in decreased compliance, is a consequence of the normal aging process. It is accompanied by an increase in systolic and pulse pressure, and an increased risk of cardiovascular morbidity and mortality. Risk factors for the development of atherosclerosis, such as hypertension, diabetes, hypercholesterolaemia, smoking and obesity are associated with 'premature vascular aging' and increased arterial stiffness.
Stiffening of the arteries, resulting in decreased compliance, is a consequence of the normal aging process. It is accompanied by an increase in systolic and pulse pressure, and an increased risk of cardiovascular morbidity and mortality. Risk factors for the development of atherosclerosis, such as hypertension, diabetes, hypercholesterolaemia, smoking and obesity are associated with 'premature vascular aging' and increased arterial stiffness. 1 To date both primary and secondary prevention of coronary heart disease has focused almost exclusively on modification of conventional risk factors. However, accumulating evidence suggests that increased vascular stiffness is not just a marker for atheromatous disease but may be an important additional risk factor, 2,3 promoting atherogenesis and acting as a link between existing risk factors and cardiovascular disease. Thus new therapeutic strategies aimed at reducing vascular stiffness could produce further reductions in cardiovascular disease. However, assessment of potential interventions requires a simple, accurate, non-invasive, and reproducible method of measuring vascular stiffness. In the current issue of the Journal of Human Hypertension, van den Berkmortel and colleagues, 4 report on the reproducibility of an ultrasound technique for the assessment of dynamic vessel wall properties. They studied cross-sectional compliance (CC) and distensibility (DC) in the common carotid and common femoral arteries of normal subjects and patients with cardiovascular risk factors. The reproducibility of these indices was 8 and 12% respectively in the carotid, and 13 and 22% in the femoral artery. There was no difference in reproducibility between normals and subjects with cardiovascular risk factors. Interestingly there was a suggestion that compliance and distensibility decreased in proportion to the number of risk factors present, although differences Correspondence: Dr JR Cockcroft, Department of Cardiology, University Hospital, Heath Park, Cardiff, Wales in age may have contributed to these findings. However, the authors provide no data as to whether the patients with risk factors exhibited any clinical manifestations of atheromatous disease, making it difficult to assess any causal relationship between vascular stiffness and cardiovascular disease. In addition to high resolution ultrasound, as used in this study, a number of other non-invasive techniques, including measurement of pulse wave velocity (PWV), 1 have also been developed to assess vascular stiffness, although each technique has its own limitations. PWV is applicable to large arterial segments only and ultrasonic techniques are limited by the ability of the method to image accurately the anterior and posterior wall of the vessel under investigation, and thus are also only applicable to large accessible arteries. Moreover all the techniques to date provide data on stiffness of single vascular beds. It is, therefore, an assumption that compliance in the arteries studied, accurately reflects compliance of the vasculature as a whole. This has important implications when such techniques are used to study the effects of therapeutic interventions.
Large arteries such as the aorta are compliant, buffering the changes in pressure resulting from intermittent ventricular ejection to sustain tissue blood flow. The rate at which aortic pressure waves travel-the pulse wave velocity-is partly determined by vascular stiffness. The aortic pressure wave is reflected from the periphery and normally returns to the aorta during diastole, thus serving to maintain coronary blood flow. As the central arteries become larger and stiffer with aging, PWV and the amplitude of the reflected wave both increase. The reflected wave then appears in the aorta earlier, changing the contour of the waveform. Peak systolic pressure is thus increased (or augmented) to a greater degree than peripheral systolic pressure as measured by sphygmomanometry. 5 This is important because it is central aortic pressure that is the major determinant of left ventricle afterload and the subsequent development of left ventricular hypertrophy, 6 which is itself an independent risk factor for cardiovascular mortality. The full arterial waveform therefore contains much more information than is provided by the extremes of pressure, including information about arterial stiffness. Quantitative analysis of the pressure waveform is now possible using the noninvasive technique of applanation tonometry, 5 allowing accurate recording of radial and carotid pulse pressure waves. By applying a reverse transfer function, which has been validated in health and disease, 7 central aortic waveforms can be accurately reconstructed and central aortic pressures determined. 8 Augmentation of central aortic pressure will thus provide a measurement of the compliance of the vascular tree in its entirety, and can be expressed numerically as the augmentation index (AIx). This technique has recently been validated and the reproducibility of the AIx shown to be better than some automated sphygmomanometers. 
Arterial stiffness and the endothelium
Although age-related increases in arterial stiffness (arteriosclerosis) are primarily structurally determined, 10 in younger subjects with one or more additional cardiovascular risk factors such as those studied by van den Berkmortel et al 4 functional stiffness may be more important. The endothelium may influence vascular stiffness through production of a number of mediators, including nitric oxide (NO) and endothelin-1. 11 Aging, hypertension, hypercholesterolaemia and diabetes have all been shown to impair endothelium-dependent vasodilatation and cause arterial stiffening. 1 Endothelial dysfunction may, therefore, predispose to atherogenesis by increasing arterial stiffness and altering shear stress. As yet there is no direct evidence of cause and effect, although studies in diabetics suggest that increased vascular stiffness may occur before atheromatous disease is clinically evident. Non-insulin dependent diabetes (NIDDM) is associated with endothelial dysfunction and decreased bioavailability of NO. Pulse wave abnormalities consistent with increased stiffness are detectable early in the course of the disease in asymptomatic patients. 12 Fish oil improves endothelial function in NIDDM and decreases arterial stiffness. 13 Further studies are needed in other cardiovascular disease states, but non-invasive assessment of arterial stiffness may provide a simple, reliable method with which to screen for endothelial dysfunction in populations at high cardiovascular risk; at a stage when therapeutic intervention may be of benefit.
Conclusions
Currently there is no accepted 'gold standard' for the assessment of vascular stiffness. However, the validation of a number of non-invasive techniques including that reported by van den Berkmortel et al 4 strongly suggest that increases in arterial stiffness may be an important determinant of increased cardiovascular risk. If proven, such techniques could be used to screen large patient populations and more accurately identify individuals at high cardiovascular risk at an early stage when therapeutic intervention might be most effective. Before this goal can be achieved, however, two things are required. The techniques must be validated in the clinical setting. Secondly, large scale studies need to be undertaken to discover whether arterial stiffness is a better predictor of mortality than existing risk factors. If so, future clinical studies will need to embrace this technique. Reversing vascular stiffening associated with age and disease presents a promising and important challenge for the future.
